News | October 31, 2025
Merck’s Capvaxive shows strong momentum amid industry vaccine decline
Capvaxive has recorded $530 million in cumulative sales over its first four quarters on the market
Capvaxive has recorded $530 million in cumulative sales over its first four quarters on the market
The deal reinforces GSK’s leadership in respiratory care and builds upon the company’s expanding COPD portfolio
Allergan Aesthetics reaffirms commitment to empowering girls through STEM mentorship and education initiatives
Key secondary endpoints also demonstrated statistically significant and clinically meaningful benefits with Gazyva
This approval marks a significant milestone in women’s health, introducing Bayer’s first hormone-free treatment for menopause-related symptoms
Medherant’s testosterone TEPI Patch could become the first-in-class testosterone patch developed specifically for women
Telangana aims to increase the value of the Life Sciences economy from US$ 80 billion to US$ 250 billion by 2030
With this expansion, the overall fermentation capacity of the company has increased from 450 KL to 990 KL
Medroxyprogesterone acetate-SC is a three-month contraceptive that can be administered by healthcare workers or self-injected after appropriate training
Novelix will provide financial and infrastructural support for the entire technology transfer and scale-up program
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
